P38MAPK targeting in pancreatic ductal adenocarcinoma: Promising interventional approach for breaking drug resistance and tumor control
{{output}}
Pancreatic cancer is one of the deadliest cancers and has very limited therapeutic options and a dismal prognosis with less than 11% median survival rate. Among various signaling pathways which are involved during tumor development, hyperactivation of Mitogen-... ...
